Proteomic analysis of synovial fluid from rheumatic arthritis and spondyloarthritis patients

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Svend Birkelund, Aalborg University
  • ,
  • Tue Bjerg Bennike, Aalborg University
  • ,
  • Kenneth Kastaniegaard, Aalborg University, Biogenity
  • ,
  • Mads Lausen, Aalborg University
  • ,
  • Thomas Bouet Guldbæk Poulsen, Aalborg University
  • ,
  • Tue Wenzel Kragstrup
  • Bent Winding Deleuran
  • Gunna Christiansen, Aalborg University
  • ,
  • Allan Stensballe, Aalborg University

Background: The aetiologies and pathogeneses of the joint diseases rheumatoid arthritis (RA) and spondyloarthritis (SpA) are still not fully elucidated. To increase our understanding of the molecular pathogenesis, we analysed the protein composition of synovial fluid (SF) from rheumatoid arthritis (RA) and spondyloarthritis (SpA) patients.

Methods: Fifty-six synovial fluid samples (RA, n = 32; SpA, n = 24) were digested with trypsin, and the resulting peptides were separated by liquid chromatography and analysed by tandem mass spectrometry. Additionally, the concentration of cell-free DNA (cfDNA) in the synovial fluid was measured, and plasma C-reactive protein (CRP) was determined.

Results: Three hundred thirty five proteins were identified within the SF. The more abundant proteins seen in RA SF were inflammatory proteins, including proteins originating from neutrophil granulocytes, while SpA SF had less inflammatory proteins and a higher concentration of haptoglobin. The concentration of cell-free DNA in the SF increased together with proteins that may have originated from neutrophils. Plasma CRP levels in both RA and SpA, correlated to other acute phase reactants.

Conclusions: The proteomic results underline that neutrophils are central in the RA pathology but not in SpA, and even though inhibitors of neutrophils (migration, proteinase inhibitors) were present in the SF it was not sufficient to interrupt the disease process.

Original languageEnglish
Article number29
JournalClinical Proteomics
Volume17
Number of pages15
ISSN1542-6416
DOIs
Publication statusPublished - Aug 2020

Bibliographical note

© The Author(s) 2020.

See relations at Aarhus University Citationformats

ID: 194481085